Case Study

Women In Leadership Programme​

Client: Global Investment Bank​

The objective of this programme is to support the retention, development and acceleration of female talent by providing access to coaching and targeted development, with the overall aim of strengthening the leadership pipeline by:

  • Offering a safe forum to discuss key challenges/pain points.​
  • Enhance participant’s support network – both peer and senior leaders.
  • Engaging participants in planning for a long-term career.​
  • Building skills and mind-set required to operate effectively.​
  • Motivate participants and increase their engagement with the organisation.

Topics covered over a 12-month period:

  • Defining your career strategy
  • Building your network
  • Developing resilience​
  • Navigating the organisation
  • Stepping up​
  • Leading through Strengths​
  • Virtual Presence
  • Growth Mindset​

260

Promotions

This programme has put my career in my hands. Instead of feeling upset or let down by disappointments, I find another way. Not all progress is linear, and I might move to another department instead of just upwards.
I have built so much resilience and confidence which is important for me but also so important for my team and they have already commented on this.​
Thanks for creating a safe space for us to discuss our worries and fears in the programme - and it was good to have experienced male coaches for those important “gender different" views.​

Measuring Success​

2020 Measure APAC EMEA Americas
Programme Metrics Participant # at launch 257 301 171
Participant Retention Participant # at programme close 237 283 154
Cohort retention 92% 94% 90%
Participant Progression Lateral role moves 21 37 19
In year promotions 47 61 22
Overall Cohort progression 29% 35% 27%
2018-2019 Measure Cohort 1 Cohort 2
Programme Metrics Participant # at launch 332 397
Participant Retention Participant # at programme close 286 388
Cohort retention 86% 98%
Participant Progression Lateral role moves 38 39
In year promotions 96 34
Overall Cohort progression 47% 19%